Multimedia Toolkits to Implement 12-Step Recovery Concepts in Group Counseling

March 27, 2023 updated by: Treatment Research Institute
This study is developing and testing a 12-step toolkit with five modules, training counselors to use them, and studying their frequency of use, desirability, effectiveness and patient outcomes. The toolkit includes counselor written guides, posters, client worksheets, engagement activities, and videos designed to be shown during substance abuse treatment group sessions to explain and encourage 12-step participation.

Study Overview

Detailed Description

The study has three aims. Aim 1 involves the development of an evidence-based 12-step facilitation toolkit curriculum. Toolkit structure and content is grounded in theory and empirical findings, and incorporates feedback from 12-step facilitation experts and individuals with a history of substance abuse. Aim 2 consists of implementing the resulting five-module Toolkit in a multi-site randomized controlled trial using a pre-/post-Toolkit training design that includes 1- and 6-month post-training assessments. Group counselors employed at community-based outpatient and inpatient substance abuse treatment programs will be randomly assigned to a Toolkit or treatment-as-usual condition. Data obtained from audiotaped sessions will identify between group differences in counselor adherence to 12-step content and skillfulness. Additional data will be collected on counselor satisfaction, 12-step attitudes and beliefs, and 12-step knowledge, as well as on Toolkit acceptability, feasibility, and short-term sustainability. Aim 3 will determine whether exposure to the Toolkit curriculum results in stable 12-step involvement and decreased self-reported substance use among clients.

Study Type

Interventional

Enrollment (Actual)

3483

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Jersey
      • Camden, New Jersey, United States, 08108
        • Genesis Counseling Centers
    • New York
      • Brooklyn, New York, United States, 11201
        • Phoenix House
    • Pennsylvania
      • Eagleville, Pennsylvania, United States, 19408
        • Eagleville Hospital
      • Levittown, Pennsylvania, United States, 19020
        • Livengrin Foundation
      • Philadelphia, Pennsylvania, United States, 19104
        • Penn Presbyterian
      • Philadelphia, Pennsylvania, United States, 19102
        • Rehab After Work
      • Philadelphia, Pennsylvania, United States, 19116
        • Self-Help Movement
      • Philadelphia, Pennsylvania, United States, 19132
        • Sobreity Through Outpatient
      • Philadelphia, Pennsylvania, United States, 19139
        • The Kirkbride Center
      • Philadelphia, Pennsylvania, United States, 19148
        • The Wedge Recovery Centers
      • Philadelphia, Pennsylvania, United States, 19382
        • Gaudenzia Inc.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria for Counselors:

  • Over 18 years of age
  • Employed at a participating substance abuse treatment facility
  • Provide treatment in a group format

Exclusion Criteria for Counselors:

  • At the time of the project they do not have primary responsibility for conducting at least three substance abuse group sessions per week
  • Their therapy group is normally scheduled to run less than 50 minutes, or more than 150 minutes
  • Unable to provide valid informed consent

Inclusion Criteria for Clients:

  • Over 18 years of age
  • Attending an observed group of a participating counselor
  • (For participation in the Follow-Up Study/Aim 3 only) patients must endorse heavy drinking, alcohol-related difficulties, or poor prior 12-step participation

Exclusion Criteria for Clients:

- Unable to provide valid informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Toolkit
Counselors randomized to the toolkit (TK) condition will receive a one to three hour standardized toolkit orientation that will include a description of the overall goal of the toolkit curriculum comprised of five modules, the purpose of each individual element of the toolkit, and an introduction to the toolkit teaching aids such as counselor guides, posters, and patient materials (hand-outs, sampling menus, worksheets, etc). TK counselor participants then conduct group treatment sessions using the toolkit materials with their patient participants.
The Multimedia 12-Step Toolkit includes counselor written guides, posters, client worksheets, engagement activities, and videos designed to be shown during group treatment sessions to explain and encourage 12-step participation.
Active Comparator: Treatment as Usual
Counselors assigned to the Treatment as Usual (TAU) attention control condition complete a training that reviews the same five 12-step topics that are included in the toolkit, but they do not receive any toolkit materials. TAU counselor participants then conduct group treatment sessions on the 12-step topics without using toolkit materials.
Treatment as Usual is defined as five standard 12-step facilitation group sessions as counselors would normally conduct with their clients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in counselor content adherence from baseline, as measured by the Group Observation Rating System
Time Frame: 0, 1, 6 months
Counselor adherence to 12-step concepts covered in group sessions assessed using the Group Observation Rating System which consists of items designed to assess general counseling competency skills and 12-step facilitation items
0, 1, 6 months
Change in counselor therapeutic skillfulness from baseline, as measured by the Group Observation Rating System
Time Frame: 0, 1, 6 months
Counselor therapeutic skillfulness when delivering 12-step content in group sessions assessed using the Group Observation Rating System which consists of items designed to assess general counseling competency skills and 12-step facilitation items
0, 1, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in counselor satisfaction from baseline, as measured by the Counselor Satisfaction Form
Time Frame: 0, 1, 6 months
Counselor satisfaction with their group sessions as measured by the Counselor Satisfaction Form which assesses counselors' overall satisfaction with the five 12-step groups
0, 1, 6 months
Change in counselor 12-step attitudes and beliefs from baseline, as measured by the Counselor 12-Step Attitudes and Beliefs Scale
Time Frame: 0, 1, 6 months
Counselor attitudes and beliefs about 12-step recovery and self-help approaches as measured by the Counselor 12-step Attitudes and Beliefs Scale (C-TAB) which queries about current 12-step referral practices, attitudes and beliefs about 12-step recovery and self-help approaches in general, strategies used to assist clients in engaging in the 12-step fellowship, and level of agreement with specific statements about 12-step groups
0, 1, 6 months
Change in counselor 12-step knowledge from baseline, as measured by the Counselor Core Elements of 12-step Knowledge Inventory
Time Frame: 0, 1, 6 months
Counselor knowledge about 12-step concepts as measured by the Counselor Core Elements of 12-step Knowledge Inventory (C-CETSKI), which focuses on the five toolkit content areas
0, 1, 6 months
Change in counselor feasibility and sustainability of the toolkit from baseline, as measured by a bi-weekly web-based calendar
Time Frame: 0, 1, 6 months
Feasibility and short-term sustainability will be measured via a web-based calendar which measures the type and frequency of the 12-step topics and toolkit materials counselors have used
0, 1, 6 months
Change in client involvement in 12-step activities from baseline, as measured by the Patient AA Attendance and Involvement Scale
Time Frame: 0, 2, 4, 12, 24 weeks
Number of 12-step meetings attended and engagement in other 12-step activities as measured by the Patient AA Attendance and Involvement Scale (PAIS) which assesses 12-step recovery activities
0, 2, 4, 12, 24 weeks
Change in client substance use from baseline, as measured by the Substance Use Inventory
Time Frame: 0, 2, 4, 12, 24 weeks
Self-reported alcohol and drug use as measured by the Substance Use Inventory (SUI), which is a modification of the Time-Line Follow-back Method in which a rater elicits frequency (in days) of consumption of alcohol and other illicit drugs as well as an estimate of average intensity of use
0, 2, 4, 12, 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kimberly C Kirby, PhD, Treatment Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

December 15, 2014

First Submitted That Met QC Criteria

January 6, 2015

First Posted (Estimate)

January 7, 2015

Study Record Updates

Last Update Posted (Actual)

March 28, 2023

Last Update Submitted That Met QC Criteria

March 27, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 0905
  • R01AA017867 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Drug Abuse

Clinical Trials on Multimedia 12-Step Toolkit

3
Subscribe